AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase after two documented diagnostic medial branch blocks with consistent ≥80% pain relief at the targeted facet joint level(s). The patient has failed conservative treatment and is not a candidate for radiofrequency ablation due to documented contraindications. The clinical presentation and diagnostic correlation support progression to neurolytic destruction of the lumbar or sacral paravertebral facet joint nerve(s) at a single facet joint level.
– Sequencing logic: Typically follows two successful diagnostic medial branch blocks confirming facet-mediated pain with significant pain relief, with progression to therapeutic neurolytic destruction if RFA is contraindicated or not suitable.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis includes lumbar or lumbosacral facet syndrome supporting medical necessity for neurolytic facet joint nerve destruction.
The documented diagnosis correlates with the patient's clinical symptoms, imaging excluding alternative causes, and prior diagnostic block response.
– Example ICD-10 options:
M47.816 – Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817 – Spondylosis without myelopathy or radiculopathy, lumbosacral region
M53.86 – Other specified dorsopathies, lumbar region
M53.87 – Other specified dorsopathies, lumbosacral region
SUBJECTIVE / HPI SUPPORT
Patient reports chronic moderate to severe axial low back pain localized to the lumbar/lumbosacral region, with functional limitations including standing, walking, sitting, and activities of daily living despite prior conservative care. Patient describes persistent pain lasting greater than 3 months refractory to NSAIDs, physical therapy, home exercise program, and medication management.
– Edit if needed:
low back pain
lumbosacral pain
greater than 3 months
axial pain without radiculopathy
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has previously undergone conservative management including formal physical therapy, physician-directed home exercise program, activity modification, NSAID medication trial, and prior diagnostic medial branch blocks with documented positive responses. Patient is not a candidate for RFA due to established spinal pseudarthrosis.
– Common conservative care examples:
Physical therapy for at least 6 weeks
NSAID therapy
Home exercise program
Diagnostic medial branch blocks
OBJECTIVE / DIAGNOSTIC SUPPORT
Clinical exam demonstrates tenderness localized to lumbar facet joints without radicular signs, and imaging studies including MRI exclude alternative diagnoses such as fracture, tumor, infection, or significant deformity.
Prior medial branch blocks at the target level(s) yielded consistent ≥80% sustained relief of index pain consistent with the pharmacologic agent's expected duration, supporting facet joint as the pain generator.
ASSESSMENT
Assessment: Chronic lumbar facet joint syndrome refractory to conservative management and diagnostic medial branch blocks with documented durable pain relief. Patient is not a candidate for radiofrequency ablation due to documented contraindications. Medical necessity for neurolytic destruction of the lumbar paravertebral facet joint nerve(s) to address pain and improve function is supported by clinical history, exam, imaging, and diagnostic block response.
PLAN / NEXT STEP
Plan: Proceed with neurolytic destruction by injection of the lumbar or sacral paravertebral facet joint medial branch nerve(s) with image guidance (fluoroscopy or CT) targeting the symptomatic single facet joint level. Risks, benefits, and alternatives discussed with the patient.
– Edit if needed:
lumbar levels
lumbosacral levels
right-sided
left-sided
unilateral
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Prior treatment includes two separate diagnostic medial branch blocks at the targeted lumbar or lumbosacral level(s), each providing consistent ≥80% pain relief with duration consistent with anesthetic used.
Documentation explains reason patient is not a candidate for radiofrequency ablation (e.g., spinal pseudarthrosis or presence of implanted electrical device).
Procedure performed under fluoroscopic or CT guidance; ultrasound or no image guidance is not appropriate. Moderate or deep sedation, general anesthesia, or monitored anesthesia care is not routinely used unless medically necessary and documented.
FOLLOW-UP / RESPONSE DOCUMENTATION
Patient reports at least 50% consistent pain relief for a minimum duration of 3 months along with improved ability to perform previously limited activities following neurolytic facet joint nerve destruction.
Functional improvement correlates with reduction in pain and improved activities of daily living.
– Edit if needed:
greater than 50% improvement
relief lasting at least 3 months
MISSING DOCUMENTATION CHECK
– Documentation items to confirm before scheduling/authorization:
Duration of symptoms (≥3 months)
Functional limitation and disability scale assessment
Previous conservative treatment and response
Prior diagnostic medial branch block results (at least two) with ≥80% relief
Reason for non-candidacy for RFA
Imaging and clinical correlation
Pain and disability scale documentation
Target facet joint level(s) and laterality
Current diagnosis with ICD-10 code
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested neurolytic destruction of the lumbar paravertebral facet joint nerve(s) is clinically justified based on documented chronic axial low back pain, failure of appropriate conservative treatments, positive response to two diagnostic medial branch blocks with ≥80% pain relief, and contraindication to radiofrequency ablation. This intervention supports medical necessity given the functional impairment and diagnostic correlation.
Clinical documentation confirms the procedure is the next reasonable step consistent with the patient’s condition and diagnostic findings.
CMS MEDICARE FACET JOINT INTERVENTIONS POLICY CONTEXT:
Applicable to cervical/thoracic and lumbar/sacral facet joint interventions only; excludes other joint or spinal procedures. Coverage aligns with Local Coverage Determination (LCD) L38801 version 23 and CMS Internet-Only Manuals including Medicare Benefit Policy Manual Chapter 15 Section 50, Medicare Claims Processing Manual Chapter 13, and Medicare Program Integrity Manual Chapter 13 Section 13.5.4.
PROCEDURE CODES AND CODING GUIDANCE:
Covered CPT codes include diagnostic and therapeutic paravertebral facet joint injections with image guidance (fluoroscopy or CT): 64490-64495 series for cervical/thoracic and lumbar/sacral levels; medial branch radiofrequency ablation codes 64633-64636. Each code refers to facet joints, not individual nerves. Bilateral procedures reported with modifier -50. Ultrasound guidance and non-thermal methods including chemical denervation and prolotherapy are not covered. Use KX modifier on diagnostic injections per LCD requirements. CPT 64999 is non-covered when used for non-thermal facet denervation.
ICD-10 DIAGNOSES:
Coverage supports diagnoses related to facet joint pain including spondylosis variants (M47.xxx), ankylosing hyperostosis (M48.xxx), and other specified dorsopathies (M53.xxx) pertinent to the cervical, thoracic, lumbar, or lumbosacral regions. No non-covered ICD-10 codes specified.
MEDICAL NECESSITY AND DOCUMENTATION:
Procedures must meet criteria including chronic moderate to severe axial neck or low back pain (≥3 months), documented failure of conservative management, absence of untreated radiculopathy (unless due to facet joint synovial cyst), and exclusion of alternative pathology by clinical and radiologic evaluation. Pain and disability measurements must be documented at baseline and post-procedure using consistent, standardized scales (e.g., NRS, VAS, ODI, PDAS). Documentation must justify diagnosis, treatment plan, and reasons for exclusion of radiofrequency ablation if therapeutic injections are performed.
FREQUENCY LIMITS AND UTILIZATION:
– Diagnostic injections: maximum 4 diagnostic joint sessions per spinal region per 12 months; second confirmatory diagnostic injection at same level allowed ≥2 weeks after initial.
– Therapeutic facet joint injections: maximum 4 sessions per spinal region per 12 months; requires prior diagnostic injections with ≥80% relief response; documentation must explain RFA contraindication.
– Radiofrequency ablation: initial after ≥2 diagnostic MBBs with confirmed ≥80% relief; repeat RFA allowed every ≥6 months with documented ≥50% pain or functional improvement; maximum 2 RFA sessions per spinal region per 12 months.
– Facet cyst aspiration/rupture: considered medically necessary with advanced imaging confirmation and symptoms; may be repeated once per cyst with ≥50% pain improvement for ≥3 months.
BILLING RESTRICTIONS AND DENIAL RISKS:
– Procedures without fluoroscopy or CT guidance, including those performed under ultrasound or no guidance, are non-covered.
– Use of Moderate or Deep Sedation, General Anesthesia, or Monitored Anesthesia Care (MAC) during facet injections is not reasonable; limited exceptions for RFA or cyst rupture require documented medical necessity.
– Only one spinal region per session allowed for facet joint interventions to prevent improper diagnosis.
– Multiple blocks (e.g., epidural, sympathetic) on same day as facet joint procedures uncommon and require clear documentation; frequent same-day multiple injections may trigger medical review.
– More than two levels (three or four levels) per session are non-covered.
– Therapeutic facet injections without documented RFA contraindication or performed for generalized pain syndromes (e.g., fibromyalgia, centralized pain) are not reasonable and necessary.
– Non-thermal denervation, intra-facet implants, and procedures after anterior lumbar interbody fusion (ALIF) are not covered.
PROVIDER QUALIFICATIONS:
Providers must be appropriately trained and credentialed via formal residency/fellowship or national certification/accreditation in facet joint procedures and related imaging. Non-physician providers may order/establish care plans within state scope of practice and authorization.
DOCUMENTATION EXPECTATIONS FOR CLAIMS:
Medical record must include provider assessment related to complaint, relevant history, test results, signed and dated office visit or operative reports. Claims require valid ICD-10 diagnosis codes accurately reflecting treated condition. Referring or ordering physician name and NPI must be included when applicable. Documentation must support medical necessity consistent with CMS manuals, LCD, and NCD provisions.
MODIFIER USAGE:
– Bilateral procedures require modifier -50.
– KX modifier required on diagnostic injection lines per LCD.
– Use appropriate modifiers (-RT, -LT) on ASC facility claims with bilateral procedures.
ANESTHESIA AND SEDATION:
– Moderate or deep sedation, general anesthesia, and MAC not covered for injections.
– Sedation use for RFA and cyst rupture considered only with documented medical necessity beyond patient anxiety or preference.
FREQUENCY AND REPEAT PROCEDURE RULES:
– Repeat diagnostic injections only after clinical indication and ≥2 weeks interval unless exception documented.
– Repeat RFA procedures only following documented clinical benefit ≥6 months.
– Repeat cyst aspiration allowed once per cyst with documented benefit.
NOT CLEARLY STATED IN SOURCE:
– Specific prior authorization workflow steps beyond documentation.
– Detailed record retention duration requirements.
– Limits on practitioner experience or volume thresholds.
This summary reflects CMS Medicare operational and billing policy per Article A58403 version 27 and LCD L38801 version 23 as of 04/25/2021 with effective date through 05/21/2026.